Literature DB >> 15817645

Stimulation of melatonin receptors decreases calcium levels in xenopus tectal cells by activating GABA(C) receptors.

Claudia Prada1, Susan B Udin, Allan F Wiechmann, Irina V Zhdanova.   

Abstract

To investigate the physiological effects of melatonin receptors in the Xenopus tectum, we have used the fluorescent indicator Fluo-4 AM to monitor calcium dynamics of cells in tectal slices. Bath application of KCl elicited fluorescence increases that were reduced by melatonin. This effect was stronger at the end of the light period than at the end of the dark period. Melatonin increased gamma-aminobutyric acid-C (GABA(C))-receptor activity, as demonstrated by the ability of the GABA(C)-receptor antagonists, picrotoxin and TPMPA, to abolish the effects of melatonin. In contrast, neither the GABA(A)-receptor antagonist bicuculline nor the GABA(B)-receptor antagonist CGP 35348 diminished the effects of melatonin. RT-PCR analyses revealed expression of the 3 known melatonin receptors, MT1 (Mel1(a)), MT2 (Mel1(b)), and Mel1(c). Because the effect of melatonin on tectal calcium increases was antagonized by an MT2-selective antagonist, 4-P-PDOT, we performed Western blot analyses with an antibody to the MT2 receptor; the data indicate that the MT2 receptor is expressed primarily as a dimeric complex and is glycosylated. The receptor is present in higher amounts at the end of the light period than at the end of the dark period, in a pattern complementary to the changes in melatonin levels, which are higher during the night than during the day. These results imply that melatonin, acting by MT2 receptors, modulates GABA(C) receptor activity in the optic tectum and that this effect is influenced by the light-dark cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817645     DOI: 10.1152/jn.01286.2004

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  8 in total

1.  Maternal stress induces adult reduced REM sleep and melatonin level.

Authors:  Pingfu Feng; Yufen Hu; Drina Vurbic; Yang Guo
Journal:  Dev Neurobiol       Date:  2012-05       Impact factor: 3.964

Review 2.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

3.  Distribution of MT1 melatonin receptor promoter-driven RFP expression in the brains of BAC C3H/HeN transgenic mice.

Authors:  E B Adamah-Biassi; Y Zhang; H Jung; S Vissapragada; R J Miller; M l Dubocovich
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

4.  Melatonin receptors are anatomically organized to modulate transmission specifically to cone pathways in the retina of Xenopus laevis.

Authors:  Allan F Wiechmann; David M Sherry
Journal:  J Comp Neurol       Date:  2012-04-15       Impact factor: 3.215

Review 5.  Hepatic Encephalopathy and Melatonin.

Authors:  Archana Arjunan; Dhiraj Kumar Sah; Young Do Jung; Juhyun Song
Journal:  Antioxidants (Basel)       Date:  2022-04-25

6.  Eif4a3 is required for accurate splicing of the Xenopus laevis ryanodine receptor pre-mRNA.

Authors:  Tomomi Haremaki; Daniel C Weinstein
Journal:  Dev Biol       Date:  2012-08-28       Impact factor: 3.582

Review 7.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

8.  Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?

Authors:  Mohamed A Hendaus; Fatima A Jomha; Ahmed H Alhammadi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-27       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.